Skip to main content
Veterinary Medicines

Tabernil antiasmático, solução oral para canários, pombos e aves ornamentais

Authorised
  • Dexamethasone
  • Theophylline
  • Ephedrine hydrochloride
  • Diphenhydramine hydrochloride

Product identification

Medicine name:
Tabernil antiasmático, solução oral para canários, pombos e aves ornamentais
Active substance:
  • Dexamethasone
  • Theophylline
  • Ephedrine hydrochloride
  • Diphenhydramine hydrochloride
Target species:
  • Pigeon
  • Ornamental bird
  • Common canary
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Dexamethasone
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Theophylline
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ephedrine hydrochloride
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Diphenhydramine hydrochloride
    0.80
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pigeon
    • Ornamental bird
    • Common canary
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR03DB04
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 567/01/12NFVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 21/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."